Global Blood Therapeutics Inc
(NASDAQ : GBT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.19%72.250.9%$620.88m
CELGCelgene Corporation
0.00%127.651.1%$445.33m
AMGNAmgen Inc.
0.10%167.451.1%$418.88m
BIIBBiogen Inc.
0.08%281.981.2%$356.65m
REGNRegeneron Pharmaceuticals, Inc.
0.20%468.932.7%$322.48m
VRTXVertex Pharmaceuticals Incorporated
0.24%148.481.9%$265.22m
ALXNAlexion Pharmaceuticals, Inc.
0.66%134.281.9%$219.41m
ILMNIllumina, Inc.
0.42%190.123.5%$217.26m
SRPTSarepta Therapeutics, Inc.
0.30%36.8119.8%$138.86m
INCYIncyte Corporation
-1.48%119.402.6%$129.02m
CLVSClovis Oncology, Inc.
-0.56%71.5618.0%$128.48m
KITEKite Pharma, Inc.
1.13%131.6516.1%$123.22m
TSROTESARO, Inc.
-0.09%113.7614.7%$121.57m
AAgilent Technologies, Inc.
0.56%61.591.5%$119.69m
BMRNBioMarin Pharmaceutical Inc.
0.04%80.954.4%$108.62m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.